Go Pro
NYSEARCA:IDNA

iShares Genomics Immunology and Healthcare ETF (IDNA) Price, Holdings, & News

iShares Genomics Immunology and Healthcare ETF logo
$34.57 +0.99 (+2.95%)
As of 03:19 PM Eastern

About iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA)

Advanced

Key Stats

Today's Range
$34.12
$34.57
50-Day Range
$28.65
$34.91
52-Week Range
$21.00
$34.97
Volume
24,876 shs
Average Volume
42,699 shs
Market Capitalization
$203.96 million
Assets Under Management
$197.81 million
Dividend Yield
0.81%
Net Expense Ratio
0.47%
Aggregate Rating
Moderate Buy

ETF Overview

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.

iShares Genomics Immunology and Healthcare ETF Expenses

TypeIDNATheme ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.47%0.57%0.57%0.51%0.53%
Other Expenses0.00%0.57%0.53%0.60%0.54%
Total Expense0.47%0.72%0.75%0.75%0.73%
Fee Waiver0.00%-0.72%-0.67%-0.77%-0.68%
Net Expense0.47%0.60%0.63%0.57%0.60%
Receive IDNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares Genomics Immunology and Healthcare ETF and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IDNA ETF News Headlines

iShares Genomics Immunology & Healthcare ETF
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.tc pixel
See More Headlines

IDNA ETF - Frequently Asked Questions

iShares Genomics Immunology and Healthcare ETF's stock was trading at $26.19 at the beginning of 2026. Since then, IDNA stock has increased by 30.9% and is now trading at $34.27.

Shares of IDNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that iShares Genomics Immunology and Healthcare ETF investors own include iShares Micro-Cap ETF (IWC), The RMR Group (RMR), Waste Connections (WCN), DiamondRock Hospitality (DRH), AUO (AUOTY), American Water Works (AWK) and Triple Flag Precious Metals (TFPM).

Fund Details

Issuer
iShares
Fund Name
iShares Genomics Immunology and Healthcare ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:IDNA
Inception Date
6/11/2019
Fund Manager
Jennifer Hsui, Greg Savage, Paul Whitehead
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
NYSE FactSet Global Genomics and Immuno Biopharma Index
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Holdings
62

Fund Statistics

Assets Under Management
$197.81 million
Average Daily Volume
$0.00
Discount/Premium
0.05%

Administrator, Advisor and Custodian

Administrator
State Street Bank and Trust Company
Advisor
BlackRock Fund Advisors
Custodian
State Street Bank and Trust Company
Distributor
BlackRock Investments, LLC
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Jane Street

Options

Optionable
Optionable
Options Volume
11
Put Options
1
Call Options
10
Short Interest
57,108 shs

Miscellaneous

Beta
0.93
Creation Unit
50,000
Creation Fee
$850.00
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Top 10 IDNA Holdings

IDNA Sector Exposure

IDNA Industry Exposure


This page (NYSEARCA:IDNA) was last updated on 8/7/2026 by MarketBeat.com Staff.
From Our Partners